Companies: 10,795·Total market cap: $144.5T
GlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation

GSTCOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$124111
P/E Ratio
52W High$0.0001
52W Low$0.0001
SEC Filings

GlobeStar Therapeutics Corporation (GSTC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001502152 · GSTC · OTC · as of Jun 8, 2026

Filing snapshot

213
Total Filings
15-12G
Latest Form
2025-01-14
Most Recent
2011
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001502152 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-01-19
Fiscal Year End
Jan 19, 2024
Accession No.
0001161697-24-000049
Primary Document
form_10-k.htm
Source: data.sec.gov · CIK 0001502152 · Accession 0001161697-24-000049

Latest Key Filings

10-QQuarterly Report
FORM 10-Q QUARTERLY REPORT FOR 06-30-2024
2024-10-11
8-KCurrent Report
FORM 8-K CURRENT REPORT FOR 08-08-2024
2024-10-28Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
NOTICE OF TERMINATION OF REGISTRATION
2025-01-14
View
8-KCurrent Report
FORM 8-K CURRENT REPORT FOR 08-08-2024
2024-10-28
View
10-QQuarterly Report
FORM 10-Q QUARTERLY REPORT FOR 06-30-2024
2024-10-11
View
NT 10-QNT 10-Q
FORM 12B-25 (NT 10-Q) NOTIFICATION OF LATE FILING FOR 06-30-2024
2024-08-14
View
10-QQuarterly Report
FORM 10-Q QUARTERLY REPORT FOR 03-31-2024
2024-06-28
View
NT 10-QNT 10-Q
FORM 12B-25 (NT 10-Q) NOTIFICATION OF LATE FILING FOR 03-31-2024
2024-05-17
View
10-QQuarterly Report
FORM 10-Q QUARTERLY REPORT FOR 12-31-2023
2024-03-12
View
NT 10-QNT 10-Q
FORM 12B-25 (NT 10-Q) NOTIFICATION OF LATE FILING FOR 12-31-2023
2024-02-15
View
10-KAnnual Report
FORM 10-K ANNUAL REPORT FOR 09-30-2023
2024-01-19
View
NT 10-KNT 10-K
FORM 12B-25 (NT 10-K) NOTIFICATION OF LATE FILING FOR 09-30-2023
2024-01-02
View
8-KCurrent Report
FORM 8-K CURRENT REPORT FOR 09-26-2023
2023-11-13
View
10-QQuarterly Report
FORM 10-Q QUARTERLY REPORT FOR 06-30-2023
2023-08-17
View
NT 10-QNT 10-Q
FORM 12B-25 (NT 10-Q) NOTIFICATION OF LATE FILING FOR 06-30-2023
2023-08-14
View
8-KCurrent Report
FORM 8-K CURRENT REPORT FOR 06-27-2023
2023-06-27
View
8-KCurrent Report
FORM 8-K CURRENT REPORT FOR 06-21-2023
2023-06-22
View
Showing 1–15 of 206 filingsForm 4 / 144 hidden· 213 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001502152  |  Exchange: OTC · Healthcare

GlobeStar Therapeutics Corporation (OTC: GSTC) has submitted 213 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2011. As a Healthcare sector company with CIK 0001502152, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is GlobeStar Therapeutics Corporation's most comprehensive regulatory disclosure. The most recent GlobeStar Therapeutics Corporation 10-K was filed on 2024-01-19 for fiscal year ending 2024. Historical GSTC 10-K annual reports are available from 2010 through 2024.

Investors researching GlobeStar Therapeutics Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

GSTC SEC Filings · 8 questions

GlobeStar Therapeutics Corporation (GSTC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 213 filings and access original documents at no cost. GlobeStar Therapeutics Corporation's CIK is 0001502152.

GSTC SEC filingsGlobeStar Therapeutics Corporation SEC documentsfind GSTC 10-K